BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kinoshita Y, Kawanami C, Kishi K, Nakata H, Seino Y, Chiba T. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut. 1997;41:452-458. [PMID: 9391241 DOI: 10.1136/gut.41.4.452] [Cited by in Crossref: 133] [Cited by in F6Publishing: 115] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Chiba T. Factors contributing to the development of gastric cancer due to Helicobacter pylori infection. Curr Gastroenterol Rep 2002;4:267-8. [DOI: 10.1007/s11894-002-0073-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
2 Koike T, Ohara S, Shimosegawa T. Role of gastric acid secretion in the pathogenesis of Barrett’s esophageal cancer in a Japanese population. Clin J Gastroenterol 2009;2:143-8. [DOI: 10.1007/s12328-009-0082-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
3 Akiyama T, Inamori M, Akimoto K, Iida H, Mawatari H, Endo H, Ikeda T, Nozaki Y, Yoneda K, Sakamoto Y. Risk factors for the progression of endoscopic Barrett’s epithelium in Japan: a multivariate analysis based on the Prague C & amp; M Criteria. Dig Dis Sci. 2009;54:1702-1707. [PMID: 19003532 DOI: 10.1007/s10620-008-0537-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
4 Kim N, Jung HC. The role of serum pepsinogen in the detection of gastric cancer. Gut Liver. 2010;4:307-319. [PMID: 20981206 DOI: 10.5009/gnl.2010.4.3.307] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
5 Kawanishi M. Will symptomatic gastroesophageal reflux disease develop into reflux esophagitis? J Gastroenterol 2006;41:440-3. [DOI: 10.1007/s00535-006-1791-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
6 Fujishiro H, Adachi K, Kawamura A, Katsube T, Ono M, Yuki M, Amano K, Ishihara S, Kinoshita Y. Influence of Helicobacter pylori infection on the prevalence of reflux esophagitis in Japanese patients. J Gastroenterol Hepatol 2001;16:1217-21. [DOI: 10.1046/j.1440-1746.2001.02618.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
7 Iijima K, Ohara S, Koike T, Sekine H, Shimosegawa T. Gastric acid secretion of normal Japanese subjects in relation to Helicobacter pylori infection, aging, and gender. Scand J Gastroenterol. 2004;39:709-716. [PMID: 15513353 DOI: 10.1080/00365520410005911] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
8 Fujisawa T, Adachi K, Komazawa Y, Mihara T, Azumi T, Katsube T, Furuta K, Kazumori H, Kinoshita Y. Helicobacter pylori infection prevents the occurrence of the tolerance phenomenon of histamine H2 receptor antagonists. Aliment Pharmacol Ther 2004;20:559-65. [PMID: 15339327 DOI: 10.1111/j.1365-2036.2004.02147.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
9 Nagahara A, Hojo M, Asaoka D, Watanabe S. Maintenance therapy of gastroesophageal reflux disease. Clin J Gastroenterol 2010;3:61-8. [PMID: 26189996 DOI: 10.1007/s12328-010-0139-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Kang JY. Geographical and ethnic differences in gastro-oesophageal reflux disease: SYSTEMATIC REVIEW: GEOGRAPHICAL AND ETHNIC DIFFERENCES IN GERD. Alimentary Pharmacology & Therapeutics 2004;20:705-17. [DOI: 10.1111/j.1365-2036.2004.02165.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 3.1] [Reference Citation Analysis]
11 Haruma K, Ito M. Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide. Aliment Pharmacol Ther. 2003;18:153-159. [PMID: 12925154 DOI: 10.1046/j.1365-2036.18.s1.17.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
12 Iwakiri R, Tominaga K, Furuta K, Inamori M, Furuta T, Masuyama H, Kanke K, Nagahara A, Haruma K, Kinoshita Y, Higuchi K, Takahashi S, Kusano M, Iwakiri K, Kato M, Hongo M, Hiraishi H, Watanabe S, Miwa H, Naito Y, Fujimoto K, Arakawa T. Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan. Aliment Pharmacol Ther 2013;38:729-40. [PMID: 23957383 DOI: 10.1111/apt.12444] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]
13 Inomata Y, Koike T, Ohara S, Abe Y, Sekine H, Iijima K, Ariizumi K, Yamagishi H, Kitagawa Y, Imatani A. Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status. Am J Gastroenterol. 2006;101:926-933. [PMID: 16573782 DOI: 10.1111/j.1572-0241.2006.00497.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
14 Yamao J, Kikuchi E, Matsumoto M, Nakayama M, Ann T, Kojima H, Mitoro A, Yoshida M, Yoshikawa M, Yajima H, Miyauchi Y, Ono H, Akiyama K, Sakurai G, Kinoshita Y, Haruma K, Takakura Y, Fukui H. Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy). J Gastroenterol 2006;41:1178-85. [PMID: 17287897 DOI: 10.1007/s00535-006-1952-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
15 Urita Y, Watanabe T, Ota H, Iwata M, Sasaki Y, Maeda T, Ishii T, Nanami M, Nakayama A, Kato H, Hike K, Hara N, Sanaka M, Nagai Y, Watanabe S, Nakanishi K, Nakajima H, Sugimoto M. High prevalence of gastroesophageal reflux symptoms in patients with both acute and nonacute cough. Int J Gen Med 2008;1:59-63. [PMID: 20428407 DOI: 10.2147/ijgm.s4185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
16 Van Zanten SJ, Dixon MF, Lee A. The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology. Gastroenterology. 1999;116:1217-1229. [PMID: 10220514 DOI: 10.1016/s0016-5085(99)70025-9] [Cited by in Crossref: 79] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
17 Fukuda N, Ishimura N, Okada M, Izumi D, Mikami H, Okimoto E, Aimi M, Mishiro T, Oshima N, Ishihara S, Kinoshita Y. Mucosal breaks show same circumferential distribution in majority of patients with recurrent reflux esophagitis. Endosc Int Open 2017;5:E214-21. [PMID: 28317018 DOI: 10.1055/s-0043-102401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
18 Miwa H, Osada T, Nagahara A, Ohkusa T, Hojo M, Tomita T, Hori K, Matsumoto T, Sato N. Effect of a gastro-protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: a double-blind placebo-controlled study in Japan. J Gastroenterol Hepatol 2006;21:1826-31. [PMID: 17074021 DOI: 10.1111/j.1440-1746.2006.04446.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
19 Kinoshita Y, Ishihara S. Causes of, and therapeutic approaches for, proton pump inhibitor-resistant gastroesophageal reflux disease in Asia. Therap Adv Gastroenterol 2008;1:191-9. [PMID: 21180528 DOI: 10.1177/1756283X08098181] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
20 Klinkenberg-Knol EC, Nelis F, Dent J, Snel P, Mitchell B, Prichard P, Lloyd D, Havu N, Frame MH, Romàn J. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology. 2000;118:661-669. [PMID: 10734017 DOI: 10.1016/s0016-5085(00)70135-1] [Cited by in Crossref: 390] [Cited by in F6Publishing: 93] [Article Influence: 17.7] [Reference Citation Analysis]
21 Yang A, Kang B, Choe JY, Kim HS, Kim K, Choe YH. Prevalence and Epidemiological Characteristics of Endoscopically Proven Reflux Esophagitis in Children in Korea. Pediatr Gastroenterol Hepatol Nutr 2017;20:160-6. [PMID: 29026732 DOI: 10.5223/pghn.2017.20.3.160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 Miyamoto M, Haruma K, Kuwabara M, Nagano M, Okamoto T, Tanaka M. High incidence of newly-developed gastroesophageal reflux disease in the Japanese community: a 6-year follow-up study. J Gastroenterol Hepatol 2008;23:393-7. [PMID: 17608639 DOI: 10.1111/j.1440-1746.2007.05043.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
23 Hosotani Y, Kawanami C, Hasegawa K, Watanabe T, Ito T, Oike F, Kaihara S, Okazaki K, Tanaka K, Chiba T. A role of Helicobacter pylori infection in the development of duodenal ulcer after adult living-related liver transplantation. Transplantation 2003;76:702-4. [PMID: 12973113 DOI: 10.1097/01.TP.0000080573.91725.0E] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
24 Mochizuki N, Fujita T, Kobayashi M, Yamazaki Y, Terao S, Sanuki T, Okada A, Adachi M, Murakami M, Arisaka Y, Uno K, Masuda A, Yoshida M, Umegaki E, Kutsumi H, Azuma T. Factors associated with the presentation of erosive esophagitis symptoms in health checkup subjects: A prospective, multicenter cohort study. PLoS One 2018;13:e0196848. [PMID: 29723303 DOI: 10.1371/journal.pone.0196848] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
25 Kuo P, Rayner CK, Horowitz M. Gastric emptying, diabetes, and aging. Clin Geriatr Med 2007;23:785-808, vi. [PMID: 17923338 DOI: 10.1016/j.cger.2007.06.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
26 Sharma P, Wani S, Romero Y, Johnson D, Hamilton F. Racial and geographic issues in gastroesophageal reflux disease. Am J Gastroenterol. 2008;103:2669-2680. [PMID: 19032462 DOI: 10.1111/j.1572-0241.2008.02089.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 53] [Article Influence: 5.0] [Reference Citation Analysis]
27 Katsurahara M, Imoto I, Umeda Y, Miura H, Tsuboi J, Yamada R, Yasuma T, Nakamura M, Hamada Y, Inoue H, Tanaka K, Horiki N, Gabazza EC, Takei Y. Increased Reflux Esophagitis after Helicobacter pylori Eradication Therapy in Cases Undergoing Endoscopic Submucosal Dissection for Early Gastric Cancer. Cancers (Basel) 2021;13:1779. [PMID: 33917861 DOI: 10.3390/cancers13081779] [Reference Citation Analysis]
28 Miraglia C, Moccia F, Russo M, Scida S, Franceschi M, Crafa P, Franzoni L, Nouvenne A, Meschi T, Leandro G, De' Angelis GL, Di Mario F. Non-invasive method for the assessment of gastric acid secretion. Acta Biomed 2018;89:53-7. [PMID: 30561418 DOI: 10.23750/abm.v89i8-S.7986] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Higuchi K, Shiba M, Okazaki H, Tabuchi M, Kameda N, Kadouchi K, Tominaga K, Watanabe T, Fujiwara Y, Oshitani N, Arakawa T. Four-year follow-up of the first case of gastroesophageal reflux disease treated with endoluminal gastroplication in Japan. J Gastroenterol 2007;42:325-6. [PMID: 17464463 DOI: 10.1007/s00535-007-2005-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
30 Kawai T, Yamamoto K, Fukuzawa M, Yamagishi T, Yagi K, Fukuzawa M, Kataoka M, Kawakami K, Itoi T, Sakai Y, Moriyasu F, Takagi Y, Aoki T. Helicobacter pylori infection and reflux esophagitis in young and middle-aged Japanese subjects: Helicobacter pylori and reflux esophagitis. Journal of Gastroenterology and Hepatology 2010;25:S80-5. [DOI: 10.1111/j.1440-1746.2010.06228.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
31 Miwa H, Oshima T, Tomita T, Kim Y, Hori K, Matsumoto T. Gastro-esophageal reflux disease: the recent trend in Japan. Clin J Gastroenterol 2008;1:133-8. [DOI: 10.1007/s12328-008-0039-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
32 Kanemitsu Y, Kurokawa R, Takeda N, Takemura M, Fukumitsu K, Asano T, Yap J, Suzuki M, Fukuda S, Ohkubo H, Maeno K, Ito Y, Oguri T, Niimi A. Clinical impact of gastroesophageal reflux disease in patients with subacute/chronic cough. Allergol Int 2019;68:478-85. [PMID: 31182314 DOI: 10.1016/j.alit.2019.04.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
33 Hokari K, Sugiyama T, Kato M, Saito M, Miyagishima T, Kudo M, Nishikawa K, Ishizuka J, Komatsu Y, Mizushima T. Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism. Aliment Pharmacol Ther. 2001;15:1479-1484. [PMID: 11552922 DOI: 10.1046/j.1365-2036.2001.01063.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 2.2] [Reference Citation Analysis]
34 Iwakiri K, Tanaka Y, Hayashi Y, Kotoyori M, Kawami N, Kawakami A, Sakamoto C. Association between reflux esophagitis and/or hiatus hernia and gastric mucosal atrophy level in Japan. J Gastroenterol Hepatol 2007;22:2212-6. [PMID: 18031383 DOI: 10.1111/j.1440-1746.2006.04726.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
35 Kinoshita Y, Ashida K, Hongo M; Japan Rabeprazole Study Group for NERD. Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease. Aliment Pharmacol Ther. 2011;33:213-224. [PMID: 21083596 DOI: 10.1111/j.1365-2036.2010.04508.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
36 Iijima K, Koike T, Abe Y, Ohara S, Nakaya N, Shimosegawa T. Time series analysis of gastric acid secretion over a 20-year period in normal Japanese men. J Gastroenterol 2015;50:853-61. [DOI: 10.1007/s00535-014-1031-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
37 Kinoshita Y, Sato S. Burden and cost of treatment for GERD. J Gastroenterol 2005;40:1083-4. [PMID: 16322958 DOI: 10.1007/s00535-005-1701-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
38 Abe Y, Ohara S, Koike T, Sekine H, Iijima K, Kawamura M, Imatani A, Kato K, Shimosegawa T. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Am J Gastroenterol. 2004;99:1213-1221. [PMID: 15233656 DOI: 10.1111/j.1572-0241.2004.30313.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
39 Hunt RH, Yaghoobi M. The Esophageal and Gastric Microbiome in Health and Disease. Gastroenterol Clin North Am. 2017;46:121-141. [PMID: 28164846 DOI: 10.1016/j.gtc.2016.09.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
40 Hongo M, Kinoshita Y, Haruma K. A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease. J Gastroenterol 2008;43:448-56. [PMID: 18600389 DOI: 10.1007/s00535-008-2186-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
41 Sumi S, Ishimura N, Mikami H, Okimoto E, Tamagawa Y, Mishiro T, Kinoshita Y, Ishihara S. Evaluations of Gastric Acid Pocket Using Novel Vertical 8-Channel pH Monitoring System and Effects of Acid Secretion Inhibitors. J Neurogastroenterol Motil 2021;27:370-6. [PMID: 34210902 DOI: 10.5056/jnm20115] [Reference Citation Analysis]
42 Haruma K, Hamada H, Mihara M, Kamada T, Yoshihara M, Sumii K, Kajiyama G, Kawanishi M. Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: case-control study in Japan. Helicobacter. 2000;5:24-29. [PMID: 10672048 DOI: 10.1046/j.1523-5378.2000.00003.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 2.7] [Reference Citation Analysis]
43 Hirose R, Daidoji T, Naito Y, Watanabe Y, Arai Y, Oda T, Konishi H, Yamawaki M, Itoh Y, Nakaya T. Long-term detection of seasonal influenza RNA in faeces and intestine. Clin Microbiol Infect 2016;22:813.e1-7. [PMID: 27424942 DOI: 10.1016/j.cmi.2016.06.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
44 Nakamura Y, Tamaoki J, Nagase H, Yamaguchi M, Horiguchi T, Hozawa S, Ichinose M, Iwanaga T, Kondo R, Nagata M, Yokoyama A, Tohda Y; Japanese Society of Allergology. Japanese guidelines for adult asthma 2020. Allergol Int 2020;69:519-48. [PMID: 32893125 DOI: 10.1016/j.alit.2020.08.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
45 Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T. Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori-negative and -positive Japanese subjects. J Gastroenterol 2005;40:938-44. [PMID: 16261430 DOI: 10.1007/s00535-005-1677-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
46 Shida H, Sakai Y, Hamada H, Takayama T. The daily response for proton pump inhibitor treatment in Japanese reflux esophagitis and non-erosive reflux disease. J Clin Biochem Nutr. 2013;52:76-81. [PMID: 23341702 DOI: 10.3164/jcbn.12-69] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Ishimura N, Owada Y, Aimi M, Oshima T, Kamada T, Inoue K, Mikami H, Takeuchi T, Miwa H, Higuchi K, Kinoshita Y. No increase in gastric acid secretion in healthy Japanese over the past two decades. J Gastroenterol 2015;50:844-52. [DOI: 10.1007/s00535-014-1027-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
48 Axon T. Has the human stomach passed its sell by date? Arab Journal of Gastroenterology 2009;10:43-8. [DOI: 10.1016/j.ajg.2009.04.001] [Reference Citation Analysis]
49 Goh KL. Gastroesophageal reflux disease in Asia: A historical perspective and present challenges. J Gastroenterol Hepatol. 2011;26 Suppl 1:2-10. [PMID: 21199509 DOI: 10.1111/j.1440-1746.2010.06534.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
50 Okimoto E, Ishimura N, Morito Y, Mikami H, Shimura S, Uno G, Tamagawa Y, Aimi M, Oshima N, Kawashima K. Prevalence of gastroesophageal reflux disease in children, adults, and elderly in the same community. J Gastroenterol Hepatol. 2015;30:1140-1146. [PMID: 25611309 DOI: 10.1111/jgh.12899] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
51 Miura Y, Fukuda K, Maeda T, Kurosaka M. Gastroesophageal reflux disease in patients with rheumatoid arthritis. Modern Rheumatology 2014;24:291-5. [DOI: 10.3109/14397595.2013.843749] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
52 Zaidi SF. Helicobacter pylori associated Asian enigma: Does diet deserve distinction? World J Gastrointest Oncol 2016; 8(4): 341-350 [PMID: 27096029 DOI: 10.4251/wjgo.v8.i4.341] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
53 Miwa H, Takeshima T, Iwasaki K, Hiroi S. Medical cost, incidence rate, and treatment status of gastroesophageal reflux disease in Japan: analysis of claims data. J Med Econ 2016;19:1049-55. [PMID: 27207316 DOI: 10.1080/13696998.2016.1192551] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
54 Yamagishi H, Koike T, Ohara S, Kobayashi S, Ariizumi K, Abe Y, Iijima K, Imatani A, Inomata Y, Kato K, Shibuya D, Aida S, Shimosegawa T. Prevalence of gastroesophageal reflux symptoms in a large unselected general population in Japan. World J Gastroenterol 2008; 14(9): 1358-1364 [PMID: 18322948 DOI: 10.3748/wjg.14.1358] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
55 Katsube T, Adachi K, Kawamura A, Amano K, Uchida Y, Watanabe M, Kinoshita Y. Helicobacter pylori infection influences nocturnal gastric acid breakthrough. Aliment Pharmacol Ther. 2000;14:1049-1056. [PMID: 10930899 DOI: 10.1046/j.1365-2036.2000.00799.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 2.1] [Reference Citation Analysis]
56 Sugimoto M, Murata M, Mizuno H, Iwata E, Nagata N, Itoi T, Kawai T. Endoscopic Reflux Esophagitis and Reflux-Related Symptoms after Helicobacter pylori Eradication Therapy: Meta-Analysis. J Clin Med 2020;9:E3007. [PMID: 32961949 DOI: 10.3390/jcm9093007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
57 Kawamura O, Kohata Y, Kawami N, Iida H, Kawada A, Hosaka H, Shimoyama Y, Kuribayashi S, Fujiwara Y, Iwakiri K, Inamori M, Kusano M, Hongo M. Liquid-containing Refluxes and Acid Refluxes May Be Less Frequent in the Japanese Population Than in Other Populations: Normal Values of 24- hour Esophageal Impedance and pH Monitoring. J Neurogastroenterol Motil 2016;22:620-9. [PMID: 27247103 DOI: 10.5056/jnm15195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
58 Lim SL, Goh WT, Lee JM, Ng TP, Ho KY. Changing prevalence of gastroesophageal reflux with changing time: longitudinal study in an Asian population. J Gastroenterol Hepatol. 2005;20:995-1001. [PMID: 15955205 DOI: 10.1111/j.1440-1746.2005.03887.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 2.8] [Reference Citation Analysis]
59 Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol 2009;44:518-34. [DOI: 10.1007/s00535-009-0047-5] [Cited by in Crossref: 214] [Cited by in F6Publishing: 170] [Article Influence: 16.5] [Reference Citation Analysis]
60 Hongo M, Kinoshita Y, Miwa H, Ashida K. The demographic characteristics and health-related quality of life in a large cohort of reflux esophagitis patients in Japan with reference to the effect of lansoprazole: the REQUEST study. J Gastroenterol 2008;43:920-7. [PMID: 19107335 DOI: 10.1007/s00535-008-2257-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
61 Ishimura N, Mori M, Mikami H, Shimura S, Uno G, Aimi M, Oshima N, Ishihara S, Kinoshita Y. Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers. BMC Gastroenterol 2015;15:117. [PMID: 26362795 DOI: 10.1186/s12876-015-0346-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
62 Miwa H, Go MF, Sato N. H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol. 2002;97:1106-1112. [PMID: 12014714 DOI: 10.1111/j.1572-0241.2002.05663.x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 112] [Article Influence: 6.0] [Reference Citation Analysis]
63 Ang TL, Fock KM, Dhamodaran S, Teo EK, Tan J. Racial differences in Helicobacter pylori, serum pepsinogen and gastric cancer incidence in an urban Asian population. J Gastroenterol Hepatol. 2005;20:1603-1609. [PMID: 16174081 DOI: 10.1111/j.1440-1746.2005.03898.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
64 Lien HC, Chang CS, Yeh HZ, Ko CW, Chang HY, Cheng KF, Sung FC. Increasing prevalence of erosive esophagitis among Taiwanese aged 40 years and above: a comparison between two time periods. J Clin Gastroenterol 2009;43:926-32. [PMID: 19384245 DOI: 10.1097/MCG.0b013e318191e9d5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
65 Tomita T, Yasuda T, Oka H, Terao S, Arai E, Oshima T, Fukui H, Hori K, Watari J, Miwa H. Atypical symptoms and health-related quality of life of patients with asymptomatic reflux esophagitis. J Gastroenterol Hepatol 2015;30 Suppl 1:19-24. [PMID: 25827799 DOI: 10.1111/jgh.12745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
66 Takeuchi N, Umegaki E, Takeuchi T, Murano Yukiko Yoda M, Tokioka S, Higuchi K. Gastric ulcer healing after treatment of endoscopic submucosal dissection in Japanese: comparison of H(2) receptor antagonist and proton pump inhibitor administration. J Clin Biochem Nutr 2011;49:216-21. [PMID: 22128222 DOI: 10.3164/jcbn.11-23] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
67 Youssefi M, Tafaghodi M, Farsiani H, Ghazvini K, Keikha M. Helicobacter pylori infection and autoimmune diseases; Is there an association with systemic lupus erythematosus, rheumatoid arthritis, autoimmune atrophy gastritis and autoimmune pancreatitis? A systematic review and meta-analysis study. Journal of Microbiology, Immunology and Infection 2021;54:359-69. [DOI: 10.1016/j.jmii.2020.08.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
68 Furuta K, Adachi K, Komazawa Y, Mihara T, Miki M, Azumi T, Fujisawa T, Katsube T, Kinoshita Y. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease. J Gastroenterol Hepatol. 2006;21:1581-1585. [PMID: 16928220 DOI: 10.1111/j.1440-1746.2006.04323.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
69 Blaser MJ, Saito D. Trends in reported adenocarcinomas of the oesophagus and gastric cardia in Japan. Eur J Gastroenterol Hepatol. 2002;14:107-113. [PMID: 11981333 DOI: 10.1097/00042737-200202000-00003] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 3.0] [Reference Citation Analysis]
70 Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis. 2007;8:8-14. [PMID: 17261129 DOI: 10.1111/j.1443-9573.2007.00278.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 3.7] [Reference Citation Analysis]
71 Kusunoki M, Yuki M, Ishitobi H, Kobayashi Y, Nagaoka M, Takahashi Y, Fukuba N, Komazawa Y, Shizuku T, Kinoshita Y. Effect of Age on Effectiveness of Vonoprazan in Triple Therapy for Helicobacter pylori Eradication. Intern Med 2019;58:1549-55. [PMID: 30713328 DOI: 10.2169/internalmedicine.2233-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
72 Kinoshita Y, Miwa H, Sanada K, Miyata K, Haruma K. Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia. J Gastroenterol 2014;49:628-37. [DOI: 10.1007/s00535-013-0812-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
73 Miwa H, Nakajima K, Yamaguchi K, Fujimoto K, Veldhuyzen VAN Zanten SJ, Kinoshita Y, Adachi K, Kusunoki H, Haruma K. Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects. Aliment Pharmacol Ther. 2007;26:257-264. [PMID: 17593071 DOI: 10.1111/j.1365-2036.2007.03367.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
74 Kinoshita Y, Kusano M, Iwakiri K, Fujishiro M, Tachikawa N, Haruma K. Efficacy and Safety Profile of Z-215 (Azeloprazole Sodium), a Proton Pump Inhibitor, Compared with Rabeprazole Sodium in Patients with Reflux Esophagitis: A Phase II, Multicenter, Randomized, Double-Blind, Comparative Study. Curr Ther Res Clin Exp 2018;88:26-34. [PMID: 30038671 DOI: 10.1016/j.curtheres.2018.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Toyoda M, Shirasaka D, Aoyama N, Watanabe Y, Miki I, Morita Y, Matsumoto Y, Mitani T, Miyachi H, Tamura T, Kasuga M. Impact of Helicobacter pylori Eradication Therapy on Histologic Change in the Distal Esophagus. Helicobacter 2006;11:217-23. [DOI: 10.1111/j.1523-5378.2006.00417.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
76 Wada T, Sasaki M, Kataoka H, Ogasawara N, Kanematsu T, Tanida S, Nojiri S, Ando T, Okochi M, Joh T. Gastroesophageal and Laryngopharyngeal Reflux Symptoms Correlate With Histopathologic Inflammation of the Upper and Lower Esophagus. Journal of Clinical Gastroenterology 2009;43:249-52. [DOI: 10.1097/mcg.0b013e318167b8b5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
77 Moss SF, Arnold R, Tytgat GN, Spechler SJ, Delle-Fave G, Rosin D, Jensen RT, Modlin IM. Consensus Statement for Management of Gastroesophageal Reflux Disease: result of workshop meeting at Yale University School of Medicine, Department of Surgery, November 16 and 17, 1997. J Clin Gastroenterol 1998;27:6-12. [PMID: 9706764 DOI: 10.1097/00004836-199807000-00004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
78 Haruma K, Kamada T, Kawaguchi H, Okamoto S, Yoshihara M, Sumii K, Inoue M, Kishimoto S, Kajiyama G, Miyoshi A. Effect of age and Helicobacter pylori infection on gastric acid secretion. J Gastroenterol Hepatol. 2000;15:277-283. [PMID: 10764028 DOI: 10.1046/j.1440-1746.2000.02131.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 82] [Article Influence: 4.4] [Reference Citation Analysis]
79 Kawano S, Murata H, Tsuji S, Kubo M, Tatsuta M, Iishi H, Kanda T, Sato T, Yoshihara H, Masuda E. Randomized comparative study of omeprazole and famotidine in reflux esophagitis. J Gastroenterol Hepatol. 2002;17:955-959. [PMID: 12167115 DOI: 10.1046/j.1440-1746.2002.02785.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
80 Chiba T, Seno H, Marusawa H, Wakatsuki Y, Okazaki K. Host factors are important in determining clinical outcomes of Helicobacter pylori infection. J Gastroenterol 2006;41:1-9. [PMID: 16501851 DOI: 10.1007/s00535-005-1743-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
81 Iijima K, Koike T, Abe Y, Ara N, Uno K, Imatani A, Ohara S, Shimosegawa T. Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication. J Gastroenterol 2009;44:819-25. [DOI: 10.1007/s00535-009-0066-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
82 Mario FD, Dal Bo N, Aragona G, Moussa AM, Iori V, Cavestro GM, Pilotto A, Leandro G, Franceschi M, Rugge M, Franze A. Rabeprazole in a one-week eradication therapy of Helicobacter pylori: Comparison of different dosages. J Gastroenterol Hepatol 2003;18:783-6. [DOI: 10.1046/j.1440-1746.2003.03035.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
83 Shinozaki S, Osawa H, Hayashi Y, Sakamoto H, Miura Y, Lefor AK, Yamamoto H. Vonoprazan treatment improves gastrointestinal symptoms in patients with gastroesophageal reflux disease. Kaohsiung J Med Sci. 2017;33:616-622. [PMID: 29132551 DOI: 10.1016/j.kjms.2017.07.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
84 Hirakawa K, Adachi K, Amano K, Katsube T, Ishihara S, Fukuda R, Yamashita Y, Shiozawa S, Watanabe M, Kinoshita Y. Prevalence of non-ulcer dyspepsia in the Japanese population. J Gastroenterol Hepatol. 1999;14:1083-1087. [PMID: 10574135 DOI: 10.1046/j.1440-1746.1999.02012.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
85 Bor S, Kitapcioglu G, Kasap E. Prevalence of gastroesophageal reflux disease in a country with a high occurrence of Helicobacter pyloriWorld J Gastroenterol 2017; 23(3): 525-532 [PMID: 28210089 DOI: 10.3748/wjg.v23.i3.525] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
86 Asaoka D, Nagahara A, Hojo M, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Takeda T, Komori H, Akazawa Y, Shimada Y, Osada T, Watanabe S. Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors. Biomed Rep 2016;5:165-70. [PMID: 27446535 DOI: 10.3892/br.2016.710] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
87 Axon ATR. Personal view: to treat or not to treat? Helicobacter pylori and gastro-oesophageal reflux disease - an alternative hypothesis: PERSONAL VIEW: H. PYLORI AND GERD. Alimentary Pharmacology & Therapeutics 2004;19:253-61. [DOI: 10.1111/j.1365-2036.2004.01847.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
88 Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, Furuta K, Kinoshita Y. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol. 2005;40:1005-1009. [PMID: 16211699 DOI: 10.1080/00365520510023260] [Cited by in Crossref: 115] [Cited by in F6Publishing: 106] [Article Influence: 6.8] [Reference Citation Analysis]
89 Suzuki H, Matsuzaki J, Okada S, Hirata K, Fukuhara S, Hibi T. Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan. United European Gastroenterol J 2013;1:175-83. [PMID: 24917957 DOI: 10.1177/2050640613485238] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
90 Ben Chaabane N, El Jeridi N, Ben Salem K, Hellara O, Loghmari H, Melki W, Bdioui F, Safer L, Soltani M, Saffar H. Prevalence of gastroesophageal reflux in a Tunisian primary care population determined by patient interview. Dis Esophagus. 2012;25:4-9. [PMID: 21595777 DOI: 10.1111/j.1442-2050.2011.01205.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
91 Chiba T, Watanabe T, Ito T. Helicobacter pyroli infection and acid secretion in patients with duodenal ulcer in Japan. Gut 2001;48:871-2. [PMID: 11394388 DOI: 10.1136/gut.48.6.871] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
92 Mizuno S, Matsui D, Watanabe I, Ozaki E, Kuriyama N, Watanabe Y. Serologically Determined Gastric Mucosal Condition Is a Predictive Factor for Osteoporosis in Japanese Men. Dig Dis Sci 2015;60:2063-9. [DOI: 10.1007/s10620-015-3576-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
93 Goh KL, Chang CS, Fock KM, Ke M, Park HJ, Lam SK. Gastro-oesophageal reflux disease in Asia. J Gastroenterol Hepatol. 2000;15:230-238. [PMID: 10764021 DOI: 10.1046/j.1440-1746.2000.02148.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 98] [Article Influence: 4.6] [Reference Citation Analysis]
94 Torisu T, Matsumoto T, Takata Y, Ansai T, Soh I, Awano S, Nakamichi I, Kagiyama S, Sonoki K, Yoshida A. Atrophic gastritis, but not antibody to Helicobacter pylori, is associated with body mass index in a Japanese population. J Gastroenterol. 2008;43:762-766. [PMID: 18958544 DOI: 10.1007/s00535-008-2219-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
95 Niigaki M, Adachi K, Hirakawa K, Furuta K, Kinoshita Y. Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan. J Gastroenterol 2013;48:463-72. [DOI: 10.1007/s00535-012-0671-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
96 Kim JI, Park SH, Kim JK, Chung IS, Chung KW, Sun HS. The effects of nocturnal acid breakthrough on Helicobacter pylori eradication. Helicobacter 2002;7:331-6. [PMID: 12485118 DOI: 10.1046/j.1523-5378.2002.00105.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
97 Hojo M, Ueda K, Takeda T, Akazawa Y, Ueyama H, Shimada Y, Asaoka D, Nagahara A. The relationship between Helicobacter pylori infection and reflux esophagitis and the long-term effects of eradication of Helicobacter pylori on reflux esophagitis. Therap Adv Gastroenterol 2021;14:17562848211059942. [PMID: 34917172 DOI: 10.1177/17562848211059942] [Reference Citation Analysis]
98 Ho KY, Cheung TK, Wong BC. Gastroesophageal reflux disease in Asian countries: disorder of nature or nurture? J Gastroenterol Hepatol 2006;21:1362-5. [PMID: 16911677 DOI: 10.1111/j.1440-1746.2006.04341.x] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
99 Axon A. Helicobacter pylori: What Do We Still Need to Know? Journal of Clinical Gastroenterology 2006;40:15-9. [DOI: 10.1097/01.mcg.0000190752.48621.fa] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
100 Kawara F, Fujita T, Morita Y, Uda A, Masuda A, Saito M, Ooi M, Ishida T, Kondo Y, Yoshida S, Okuno T, Yano Y, Yoshida M, Kutsumi H, Hayakumo T, Yamashita K, Hirano T, Hirai M, Azuma T. Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy. World J Gastroenterol 2017; 23(11): 2060-2067 [PMID: 28373773 DOI: 10.3748/wjg.v23.i11.2060] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
101 Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis. 2007;8:179-185. [PMID: 17970873 DOI: 10.1111/j.1751-2980.2007.00304.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
102 Yuasa N, Abe T, Sasaki E, Fukaya M, Nimura Y, Miyahara R. Comparison of gastroesophageal reflux in 100 patients with or without prior gastroesophageal surgery. J Gastroenterol. 2009;44:650-658. [PMID: 19434363 DOI: 10.1007/s00535-009-0055-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
103 Cho YS, Choi MG, Jeong JJ, Chung WC, Lee IS, Kim SW, Han SW, Choi KY, Chung IS. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol. 2005;100:747-753. [PMID: 15784014 DOI: 10.1111/j.1572-0241.2005.41245.x] [Cited by in Crossref: 132] [Cited by in F6Publishing: 125] [Article Influence: 7.8] [Reference Citation Analysis]
104 Fujimoto K, Hongo M. Risk factors for relapse of erosive GERD during long-term maintenance treatment with proton pump inhibitor: a prospective multicenter study in Japan. J Gastroenterol. 2010;45:1193-1200. [PMID: 20607308 DOI: 10.1007/s00535-010-0276-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
105 Arihiro S, Kato T, Ito K, Saruta M, Nikami T, Suzuki T, Tajiri H. Correlation between symptomatic improvement and quality of life in patients with reflux and dyspeptic symptoms. J Clin Biochem Nutr 2012;50:205-10. [PMID: 22573922 DOI: 10.3164/jcbn.11-71] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
106 Hayashi Y, Iwakiri K, Kotoyori M, Sakamoto C. Mechanisms of acid gastroesophageal reflux in the Japanese population. Dig Dis Sci 2008;53:1-6. [PMID: 17978874 DOI: 10.1007/s10620-007-0038-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
107 Jones J, Hawkey C. Physiology and organ-related pathology of the elderly: stomach ulcers. Best Practice & Research Clinical Gastroenterology 2001;15:943-61. [DOI: 10.1053/bega.2001.0251] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
108 Miki M, Adachi K, Azumi T, Koshino K, Furuta K, Kinoshita Y. A comparative study of intragastric acidity during post-breakfast and pre-dinner administration of low-dose proton pump inhibitors: a randomized three-way crossover study. Aliment Pharmacol Ther 2006;24:1445-51. [PMID: 17032285 DOI: 10.1111/j.1365-2036.2006.03140.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
109 Wen S, Wang S, Niu S, Zhang M, Shi C, Qiu Z, Xu X, Yu L. Sensitivity and specificity of combination of Hull airway reflux questionnaire and gastroesophageal reflux disease questionnaire in identifying patients with gastroesophageal reflux-induced chronic cough. Ann Transl Med 2020;8:1564. [PMID: 33437763 DOI: 10.21037/atm-20-3236] [Reference Citation Analysis]
110 Kamada T, Haruma K, Kusunoki H, Miyamoto M, Ito M, Kitadai Y, Yoshihara M, Chayama K, Tahara K, Kawamura Y. Significance of an exaggerated meal-stimulated gastrin response in pathogenesis of Helicobacter pylori-negative duodenal ulcer. Dig Dis Sci. 2003;48:644-651. [PMID: 12741450 DOI: 10.1023/a:1022808003014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
111 Higuchi K, Fujiwara Y, Okazaki H, Tabuchi M, Kameda N, Kadouchi K, Machida H, Tanigawa T, Shiba M, Watanabe T. Feasibility, safety, and efficacy of the Stretta procedure in Japanese patients with gastroesophageal reflux disease: first report from Asia. J Gastroenterol. 2007;42:205-210. [PMID: 17380278 DOI: 10.1007/s00535-006-1944-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
112 Kamada T, Haruma K, Kusunoki H, Miyamoto M, Ito M, Kitadai Y, Yoshihara M, Chayama K, Tahara K, Kawamura Y. Significance of an exaggerated meal-stimulated gastrin response in pathogenesis of Helicobacter pylori-negative duodenal ulcer. Dig Dis Sci. 2003;48:644-651. [PMID: 12741450 DOI: 10.1016/s0016-5085(03)82254-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
113 Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology. 2002;123:92-105. [PMID: 12105837 DOI: 10.1053/gast.2002.34156] [Cited by in Crossref: 244] [Cited by in F6Publishing: 235] [Article Influence: 12.2] [Reference Citation Analysis]
114 Iwakiri K. The role of excessive esophageal acid exposure in patients with gastroesophageal reflux disease. Clin J Gastroenterol 2009;2:371-9. [PMID: 26192789 DOI: 10.1007/s12328-009-0125-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
115 Amano K, Adachi K, Katsube T, Watanabe M, Kinoshita Y. Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly. J Gastroenterol Hepatol 2001;16:132-6. [PMID: 11207891 DOI: 10.1046/j.1440-1746.2001.02408.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 4.0] [Reference Citation Analysis]
116 Funaki Y, Ogasawara N, Kawamura Y, Yoshimine T, Tamura Y, Izawa S, Ebi M, Sasaki M, Kasugai K. Effects of acotiamide on functional dyspepsia patients with heartburn who failed proton pump inhibitor treatment in Japanese patients: A randomized, double-blind, placebo-controlled crossover study. Neurogastroenterol Motil 2020;32:e13749. [PMID: 31612597 DOI: 10.1111/nmo.13749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
117 Kinoshita Y, Kato M, Fujishiro M, Masuyama H, Nakata R, Abe H, Kumagai S, Fukushima Y, Okubo Y, Hojo S, Kusano M. Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study. J Gastroenterol 2018;53:834-44. [PMID: 29188387 DOI: 10.1007/s00535-017-1417-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
118 Shih GL, Brensinger C, Katzka DA, Metz DC. Influence of age and gender on gastric acid secretion as estimated by integrated acidity in patients referred for 24-hour ambulatory pH monitoring. Am J Gastroenterol 2003;98:1713-8. [PMID: 12907323 DOI: 10.1111/j.1572-0241.2003.07586.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]